Literature DB >> 15795159

Imaging of atherosclerosis -- can we predict plaque rupture?

James H F Rudd1, John R Davies, Peter L Weissberg.   

Abstract

Rupture of so-called vulnerable or unstable atherosclerotic lesions is responsible for a significant proportion of myocardial infarcts and strokes. However, timely identification of such plaques, in order to allow for aggressive local and systemic therapy, remains problematic. In order to address this problem, there is a need to develop techniques that can image the cellular, biochemical, and molecular components that typify the vulnerable plaque. In this article, both techniques that are in current clinical use and those being evaluated in clinical trials are reviewed with regard to their ability to identify unstable lesions at risk of rupture.

Entities:  

Mesh:

Year:  2005        PMID: 15795159     DOI: 10.1016/j.tcm.2004.12.001

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  11 in total

1.  Targeted PARACEST nanoparticle contrast agent for the detection of fibrin.

Authors:  Patrick M Winter; Kejia Cai; Junjie Chen; Christopher R Adair; Garry E Kiefer; Phillip S Athey; Patrick J Gaffney; Carolyn E Buff; J David Robertson; Shelton D Caruthers; Samuel A Wickline; Gregory M Lanza
Journal:  Magn Reson Med       Date:  2006-12       Impact factor: 4.668

Review 2.  Spectroscopy to improve identification of vulnerable plaques in cardiovascular disease.

Authors:  Janneke L M Bruggink; Robbert Meerwaldt; Gooitzen M van Dam; Joop D Lefrandt; Riemer H J A Slart; René A Tio; Andries J Smit; Clark J Zeebregts
Journal:  Int J Cardiovasc Imaging       Date:  2009-09-17       Impact factor: 2.357

Review 3.  An advanced ultrasound application used to assess peripheral vascular diseases: superb microvascular imaging.

Authors:  Wakana Sato; Yuta Suto; Takayuki Yamanaka; Hiroyuki Watanabe
Journal:  J Echocardiogr       Date:  2021-04-15

4.  Parametric subharmonic imaging using a commercial intravascular ultrasound scanner: an in vivo feasibility study.

Authors:  John R Eisenbrey; Anush Sridharan; Ebo D deMuinck; Marvin M Doyley; Flemming Forsberg
Journal:  J Ultrasound Med       Date:  2012-03       Impact factor: 2.153

5.  Reproducibility of black blood dynamic contrast-enhanced magnetic resonance imaging in aortic plaques of atherosclerotic rabbits.

Authors:  Claudia Calcagno; Esad Vucic; Venkatesh Mani; Gregg Goldschlager; Zahi A Fayad
Journal:  J Magn Reson Imaging       Date:  2010-07       Impact factor: 4.813

6.  Chemokine receptors: Key for molecular imaging of inflammation in atherosclerosis.

Authors:  Yongjian Liu; Pamela K Woodard
Journal:  J Nucl Cardiol       Date:  2018-03-07       Impact factor: 5.952

7.  Intravascular detection of inflamed atherosclerotic plaques using a fluorescent photosensitizer targeted to the scavenger receptor.

Authors:  Ahmed Tawakol; Ana P Castano; Faten Gad; Touqir Zahra; Gregory Bashian; Raymond Q Migrino; Atosa Ahmadi; Jeremy Stern; Florencia Anatelli; Stephanie Chirico; Azadeh Shirazi; Sakeenah Syed; Alan J Fischman; James E Muller; Michael R Hamblin
Journal:  Photochem Photobiol Sci       Date:  2007-10-29       Impact factor: 3.982

8.  Preparation and initial characterization of biodegradable particles containing gadolinium-DTPA contrast agent for enhanced MRI.

Authors:  Amber L Doiron; Kevin Chu; Adeel Ali; Lisa Brannon-Peppas
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-16       Impact factor: 11.205

9.  In vivo imaging of the effect of LPS on arterial endothelial cells: molecular imaging of heat shock protein 60 expression.

Authors:  Marius C Wick; Christina Mayerl; Aleksandar Backovic; Ruurd van der Zee; Werner Jaschke; Hermann Dietrich; Georg Wick
Journal:  Cell Stress Chaperones       Date:  2008-05-09       Impact factor: 3.667

Review 10.  In vivo molecular imaging of vascular stress.

Authors:  Marius C Wick; Christian Kremser; Stefan Frischauf; Georg Wick
Journal:  Cell Stress Chaperones       Date:  2008-05-09       Impact factor: 3.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.